Advertisement

Responsive Advertisement
surge in prevalence of chronic and genetic diseases drive the growth of the global prime editing and CRISPR market
Azoles projected to be the primary drug type in the near future
Rise in Incidence of Chronic Disorders and Geriatric Population
Rapid acting insulin is one of the fastest acting insulin that starts working within 15 minutes of its introduction.
The U.S. cardiac resynchronization therapy market is classified into intraventricular dyssynchrony, interventricular dyssynchrony,
The Covid-19 pandemic severely disrupted the workflow in the healthcare industry
Rise in number of surgical procedures contributes to the market growth
Infectious disease segment is anticipated to show significant growth during the forecast period
Ethical issues and lack of safety toward gene editing restrain the growth to some extent.
The consumables segment is projected to register the highest CAGR of 6.0% during the forecast period
Increase in prevalence of chronic diseases, surge in geriatric populations
Rise in the geriatric population, increase in the prevalence of cardiovascular diseases